Een handige diagnose met 'MyDiagnostick'

European Heart Rhythm Association; Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

New oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and patients will have to learn how to use these drugs effectively and safely in clinical practice. Many unresolved questions on how to optimally use these drugs in specific clinical situations remain. 

The European Heart Rhythm Association set out to co- ordinate a unified way of informing physicians on the use of the different NOACs. A writing group listed 15 topics of concrete clinical scenarios and formulated as practical answers as possible based on available evidence. The 15 topics are: (1) Practical start-up and follow-up scheme for patients on NOACs; (2) How to measure the anticoagulant effect of NOACs; (3) Drug–drug interactions and pharmacokinetics of NOACs; (4) Switching between anticoagulant regimens; (5) Ensuring compliance of NOAC intake; (6) How to deal with dosing errors; (7) Patients with chronic kidney disease; (8) What to do if there is a (suspected) overdose without bleeding, or a clotting test is indicating a risk of bleeding? (9) Management of bleeding complications; (10) Patients undergoing a planned surgical intervention or ablation; (11) Patients undergoing an urgent surgical intervention; (12) Patients with AF and coronary artery disease; (13) Cardioversion in a NOAC-treated patient; (14) Patients presenting with acute stroke while on NOACs; (15) NOACs vs. VKAs in AF patients with a malignancy. Since new information is becoming available at a rapid pace, an EHRA Web site with the latest updated information accompanies this text (

The accuracy of MyDiagnostick to detect AF
Atrial fibrillation is very common in people aged 65 or older. This condition increases the risk of death, congestive heart failure and thromboembolic conditions. Many patients with atrial fibrillation are asymptomatic and a cerebrovascular accident (CVA) is often the first clinical presentation. Guidelines concerning the preven
MyDiagnostick study results in Europace
We are pleased to announce that the results of the latest study about the AF detection performance of MyDiagnostick are published in Europace Journal.
"Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation, R.G. Tieleman et. al"
Interview with General Manager Maurice Voncken
Screening for AF by pulse assessments effective?
Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice.
Results validation study
Results from the validation study performed with MyDiagnostick at the Martini Hosptial in Groningen, The Netherands
Zorgidee Award 2013 for MyDiagnostick
the Flemish Minister of Welfare Jo Vandeurzen presented The 'Zorgidee Award 2013' to MyDiagnostick Medical
MyDiagnostick reveals new AF cases
In a general practioners office MyDiagnostick detects new AF cases
CE Certificate MyDiagnostick approved
Process CE Certification MyDiagnostick started.
MyDiagnostick CE pending
Validation trial MyDiagnostick started.
Dr. Robert Tieleman of the Martini Hospital in Groningen the Netherlands, is the key investigator for the validation trial for MyDiagnostick.
MyDiagnostick concept at Innovation conference